CONSUN PHARMA ( 1681.HK) - Stock Earnings
1681.HK Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q2 | 148.4 million HKD | 496.8 million HKD |
| 2022Q1 | 148.4 million HKD | 496.8 million HKD |
| 2021Q4 | 169.8 million HKD | 579.1 million HKD |
| 2021Q3 | 169.8 million HKD | 579.1 million HKD |
1681.HK Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | 590.2 million HKD | 2.0 billion HKD |
| 2020 | 498.8 million HKD | 1.8 billion HKD |
| 2019 | 79.8 million HKD | 1.7 billion HKD |
| 2018 | 465.4 million HKD | 1.8 billion HKD |
1681.HK
Price: HK$9.47
Dividend Yield: 6.61%
Forward Dividend Yield: 6.30%
Payout Ratio: 52.63%
Dividend Per Share: 0.60 HKD
Earnings Per Share: 1.17 HKD
P/E Ratio: 7.87
Exchange: HKG
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 1.5 million
Market Capitalization: 7.7 billion
Average Dividend Frequency: 2
Years Paying Dividends: 12
DGR3: 22.62%
DGR5: 11.57%